Mikiya Kishi

Mr. Mikiya Kishi

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
JYJoto Yoshimoto
Joto Yoshimoto
YKYukiko Kato
Yukiko Kato
MBMasayasu Ban
Masayasu Ban
MKMikiya Kishi
Mikiya Kishi
HHHumitoshi Horie
Humitoshi Horie
YNYasuhiro Nishizaki
Yasuhiro Nishizaki
Legumes are low-carbohydrate food and are abundant in dietary fiber. In order to provide a functional staple food that does not cause a rapid increase in postprandial blood glucose levels, four kinds of legumes were focused on as ingredients. Noodles made from dehulled yellow pea, unshelled yellow pea, chickpea, and lentil were prepared and evaluated as functional staple foods for controlling blood glucose via an in vitro digestion method. We also measured breaking stress and breaking strain using a creep meter, as well as sensory tests on a 9-point hedonic scale. The noodles made from yellow pea had high values for both breaking stress and breaking strain, and was highly regarded in the sensory tests. Therefore, the noodles made from yellow pea on postprandial glucose and insulin response were measured in a randomized double-blind study (n = 12). The results show that noodles made from yellow pea have a low glycemic index (50.4), and have potential as a functional staple food.

5 January 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
YTYoshihiro TSUCHIYA
Yoshihiro TSUCHIYA
JYJoto Yoshimoto
Joto Yoshimoto
HKHiroto Kobayashi
Hiroto Kobayashi
SISho Ishii
Sho Ishii
MKMikiya Kishi
Mikiya Kishi
Salt and carbohydrates, two causes of elevated blood glucose, are essential components for survival; however, excessive intake of either is a known health risk. In a previous study, we reported the usefulness of pasta prepared from yellow pea (YPP) as a functional staple food that is beneficial for blood sugar control. In this study, we investigated the usefulness of YPP in reducing health risks by examining its effects on saltiness, postprandial satisfaction, and second meal. The results showed that YPP tasted saltier than conventional pasta made from semolina wheat when prepared with a 0.75% salt concentration. In addition, we examined blood glucose levels, insulin secretion, and postprandial hunger over a longer period than in previous studies. We observed that when the same amount of YPP and wheat pasta were eaten, the elevation in blood glucose and insulin secretion was lower after YPP consumption while maintaining a similar level of satiety. Furthermore, YPP was also observed to be able to suppress elevated insulin levels at the second meal.

3 September 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
KDKanako Deguchi
Kanako Deguchi
JYJoto Yoshimoto
Joto Yoshimoto
RWRisako Wada
Risako Wada
CUChihiro Ushiroda
Chihiro Ushiroda
KYKotone Yanagi
Kotone Yanagi
Katsumi IizukaKatsumi Iizuka
Katsumi Iizuka
A conventional questionnaire-based assessment of acetic acid intake is based on the intake of seasonings such as mayonnaise, which could thereby lead to an underestimation. We here determine the relationships of acetic acid intake with nutrient intake estimated using a food recording app (Asken) based on meal recipes. A total of 141 individuals (48 men and 93 women) used the app for at least 7 days per month. The mean daily intake of acetic acid was 0.16 ± 0.19 g and the mean frequency of acetic acid intake was 2.77 ± 1.66 days per week. A multivariate regression analysis adjusted for age, sex, BMI, and energy intake revealed that the amount of acetic acid consumed was significantly and positively associated with the intake of protein (11.9 (5.1, 18.6), p < 0.001), cholesterol (80.7 (4.5, 156.9), p = 0.04), and all vitamins except vitamin K. The frequency of acetic acid intake was significantly and positively associated with protein (1.04 (0.20, 1.87), p = 0.015), vitamin B1 (0.3 (0.02,0.5), p = 0.031), niacin (0.5 (0.04,1.0), p = 0.032), and vitamin B12 (0.4 (0.1,0.7), p = 0.002) intake, suggesting that individuals who frequently consume acetic acid tend to consume more protein and some vitamins. Thus, the amount and frequency of acetic acid may reflect protein and vitamin intake.

19 January 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
RWRisako Wada
Risako Wada
JYJoto Yoshimoto
Joto Yoshimoto
YKYoshino Kodaira
Yoshino Kodaira
KDKanako Deguchi
Kanako Deguchi
YAYuto Aoki
Yuto Aoki
Katsumi IizukaKatsumi Iizuka
Katsumi Iizuka
Background: Acetic acid has been suggested to have health benefits. Our previous exploratory study linked acetic acid intake to higher protein and vitamin consumption, but relationships with age and sex remained unclear. Objective: This study examined associations between acetic acid intake, age, and sex, and explored nutrient correlates after adjusting for age, sex, and energy intake. Methods: Dietary data from 12,074 Japanese adults aged 20–69 years, collected via the Asken food-tracking app, were analyzed. Two-way ANOVA assessed effects of age, sex, and their interaction on acetic acid intake. Multiple linear regressions examined associations between acetic acid intake and nutrient intakes. Model 1 adjusted for age and sex; Model 2 additionally adjusted for total energy intake. Results: Participants included 3038 men (47.8 ± 11.9 y) and 9036 women (42.4 ± 11.8 y). Acetic acid intake was higher among men and older participants (sex: F = 11.0, p < 0.001; age: F = 9.1, p < 0.001). In Model 1, acetic acid intake correlated positively with most nutrients. After adjusting for energy (Model 2), negative associations were found with carbohydrates, sugars, starches, saturated fat, and butyric acid (all p < 0.05). Conclusions: Individuals with higher acetic acid intake tended to consume fewer carbohydrates and saturated fats, even at equivalent energy intake. These findings suggest that acetic acid-containing diets may reduce the intake of starches and saturated fatty acids, potentially contributing to obesity prevention.

29 August 2026 in European Journal of Nutrition
Verified
Journal Article
Open access
PDF file
HSHitoshi Shimbo
Hitoshi Shimbo
MIMamoru Ito
Mamoru Ito
YAYuto Aoki
Yuto Aoki
JYJoto Yoshimoto
Joto Yoshimoto
MKMikiya Kishi
Mikiya Kishi
AYAkiko Yagami
Akiko Yagami
Purpose: Increasing attention has been paid to individuals who report gastrointestinal symptoms following wheat consumption. In addition to wheat allergy and celiac disease, non-celiac gluten sensitivity (NCGS) has been proposed as a clinical entity. Despite persistent symptoms, many affected individuals continue to consume wheat-containing foods. We aimed to investigate the impact of replacing wheat-based foods with gluten-reduced foods, specifically yellow pea pasta (YPP), bread (YPB), and chips (YPC), on the abdominal symptoms, quality of life (QOL), and gut microbiota in healthy individuals who habitually consume wheat frequently. Methods: Thirty men and women aged 18–64 years with habitual high wheat intake were enrolled and divided into two groups based on the presence or absence of abdominal symptoms. Participants followed a 4-week gluten-reduced diet intervention using YPP, YPB, and YPC. Abdominal symptoms, QOL, gut microbiota, and selected blood biomarkers were evaluated before and after the intervention. Results: The intervention led to significant improvement in abdominal distension, abdominal pain or discomfort, feeling of incomplete evacuation , hard stools, and urgent need for defecation. Baseline QOL differences between groups were no longer evident. Analysis of gut microbiota revealed maintenance and/or an increase in short-chain fatty acid-producing bacteria, with significant correlations observed between specific bacterial shifts and symptom improvement. Conclusions: Yellow pea–based products (YPP, YPB, and YPC) may represent a promising dietary strategy for alleviating abdominal symptoms in individuals with high wheat consumption. This study was registered in the UMIN Clinical Trials Registry (UMIN Trial ID: UMIN000056466).